Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep 1;106(5):1864-6.
doi: 10.1182/blood-2005-03-1159. Epub 2005 May 10.

Time-course Analysis of Hepcidin, Serum Iron, and Plasma Cytokine Levels in Humans Injected With LPS

Affiliations

Time-course Analysis of Hepcidin, Serum Iron, and Plasma Cytokine Levels in Humans Injected With LPS

Erwin Kemna et al. Blood. .

Abstract

Hepatic peptide hormone hepcidin is the key regulator of iron metabolism and the mediator of anemia of inflammation. Previous studies indicated that interleukin-6 (IL-6) mediates hepcidin increase and consequent hypoferremia during inflammation. Here we used an in vivo human endotoxemia model to analyze the effects of lipopolysaccharide (LPS) as a more upstream inflammation activator. The temporal associations between plasma cytokines, hepcidin levels, and serum iron parameters were studied in 10 healthy individuals after LPS injection. IL-6 was dramatically induced within 3 hours after injection, and urinary hepcidin peaked within 6 hours, followed by a significant decrease in serum iron. Serum prohepcidin showed no significant change within a 22-hour time frame. These in vivo human results confirm the importance of the IL-6-hepcidin axis in the development of hypoferremia in inflammation and highlight the rapid responsiveness of this iron regulatory system.

Similar articles

See all similar articles

Cited by 140 articles

See all "Cited by" articles

LinkOut - more resources

Feedback